Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Metagenomi, Inc. - Common Stock
(NQ:
MGX
)
1.770
+0.215 (+13.83%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
584,747
Open
1.560
Bid (Size)
1.560 (100)
Ask (Size)
1.900 (200)
Prev. Close
1.555
Today's Range
1.560 - 1.785
52wk Range
1.230 - 4.920
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
December 01, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi to Present at Jefferies Global Healthcare Conference in London
November 17, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Performance
YTD
-53.3%
-53.3%
1 Month
-26.9%
-26.9%
3 Month
-1.1%
-1.1%
6 Month
+4.1%
+4.1%
1 Year
-12.8%
-12.8%
More News
Read More
Metagenomi Prioritizes Hemophilia A Program, Lays Off 25% Workforce
↗
November 12, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
November 12, 2025
Via
Benzinga
These stocks are moving in today's after hours session
↗
November 11, 2025
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
November 11, 2025
Via
Benzinga
Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates
November 11, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development
November 11, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Inc (NASDAQ:MGX) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected
↗
August 12, 2025
Via
Chartmill
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
August 12, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors
August 11, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Which stocks are gapping on Wednesday?
↗
July 09, 2025
Via
Chartmill
Sam Altman Says He 'Didn't Think' Elon Musk Would Abuse Government Power, Tesla CEO Hits Back With 'Scam Altman' Jibe
↗
June 20, 2025
Via
Benzinga
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
↗
June 18, 2025
Via
Benzinga
Demystifying Metagenomi: Insights From 4 Analyst Reviews
↗
May 15, 2025
Via
Benzinga
Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
↗
May 15, 2025
Via
Benzinga
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
May 14, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results
May 13, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi to Present at Upcoming Scientific Meetings
May 02, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Reports Business Updates and Full Year 2024 Financial Results
March 17, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week
↗
March 16, 2025
Via
Stocktwits
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems
March 13, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
February 11, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Stargate, Netflix, GE Aerospace, Twilio, and More
↗
January 29, 2025
Via
The Motley Fool
Trump’s “Stargate AI” Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
January 22, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Government
Frequently Asked Questions
Is Metagenomi, Inc. - Common Stock publicly traded?
Yes, Metagenomi, Inc. - Common Stock is publicly traded.
What exchange does Metagenomi, Inc. - Common Stock trade on?
Metagenomi, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Metagenomi, Inc. - Common Stock?
The ticker symbol for Metagenomi, Inc. - Common Stock is MGX on the Nasdaq Stock Market
What is the current price of Metagenomi, Inc. - Common Stock?
The current price of Metagenomi, Inc. - Common Stock is 1.770
When was Metagenomi, Inc. - Common Stock last traded?
The last trade of Metagenomi, Inc. - Common Stock was at 12/03/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today